Loading clinical trials...
Loading clinical trials...
Facioscapulohumeral muscular dystrophy (FSHD) is characterized by early and significant involvement of facial muscles; however, objective imaging data focusing on facial muscles are limited. Facial ul...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Koç University
NCT06672237 · Neuromuscular Disease, Neuromuscular Diseases (NMD), and more
NCT06907875 · Facioscapulohumeral Muscular Dystrophy
NCT06084026 · Neuromuscular Diseases
NCT07357428 · Amyotrophic Lateral Sclerosis, Neuromuscular Disease, and more
NCT06151600 · Peripheral Neuropathy, Neuro-Degenerative Disease, and more
Koç University Hospital
Istanbul, Istanbul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions